Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: Analyzing material from the HC registry

Pediatric and Developmental Pathology

Volumn 14, Issue 5, 2011, Pages 370-377

  Shehata, Bahig M ^a,b   Bouzyk, Mark ^b   Shulman, Sarah C ^a   Tang, Weining ^b   Steelman, Charlotte K ^a   Davis, Gigi K ^a   Moreno, Carlos S ^b  

^a Children's Healthcare of Atlanta ^*  (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Histiocytoid cardiomyopathy; SIDS; Whole genome DASL

Indexed keywords

CALGRANULIN A; CALGRANULIN B; COMPLEMENTARY DNA; GENOMIC DNA; INTERLEUKIN 33; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA;

ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; HISTIOCYTOID CARDIOMYOPATHY; HUMAN; HUMAN TISSUE; INFANT; MALE; MOLECULAR GENETICS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARDIOMYOPATHIES; DNA; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYOCARDIUM; PURKINJE FIBERS; REGISTRIES; RNA;

EID: 84855364192     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-05-0826-OA.1     Document Type: Article

References (38)

1. Shehata BM, Patterson K, Thomas JE, Scala-Barnett, Dasu S, Robinson HB. Histiocytoid cardiomyopathy: three new cases and a review of the literature. Pediatr Dev Pathol 1998;1:56-69. (Pubitemid 128542112)
2. Voth D. On arachnocytosis of the myocardium (a contribution to the problem of rhabdomyoma of the heart). Frankf Z Pathol 1962;71: 646-656.
3. Bruton D, Herdson PB, Becroft DMO. Histiocytoid cardiomyopathy of infancy: an unexplained myofibre degeneration. Pathology 1977; 9:115-122. (Pubitemid 8124280)
4. Suarez V, Fuggle WJ, Cameron AH, French TA, Hollingworth T. Foamy myocardial transformation of infancy: an inherited disease. J Clin Pathol 1987;40:329-334. (Pubitemid 17023664)
5. Shehata BM, Burke AP, Tazelaar H, et al. Benign tumors with myocyte differentiation. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds.World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004;254-259.
6. Saffitz JE, Ferrans VJ, Rodriguez ER, Lewis FR, Roberts WC. Histiocytoid cardiomyopathy: a cause of sudden death in apparently health infants. Am J Cardiol 1983;52:215-217. (Pubitemid 13061359)
7. Cunningham NE, Stewart J. A rare cause of cot death: infantile xanthomatous cardiomyopathy. Med Sci Law 1985;25:149-152. (Pubitemid 15066067)
8. Andreu AL, Checcarelli N, Iwata S, Shanske S, Di Mauro S. A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy. Pediatr Res 2000; 48:311-314. (Pubitemid 30637329)
9. Cohen-Barak O, Hagiwara N, Arlt MF, Horton JP, Brilliant MH. Cloning, characterization and chromosome mapping of the human SOX6 gene. Gene 2001;265:157-164. (Pubitemid 32209261)
10. Vallance HD, Jeven G, Wallace DC, Brown MD. A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344G (MERRF) mitochondrial DNA mutation. Pediatr Cardiol 2004;25: 538-540. (Pubitemid 39382825)
11. Bird LM, Krous HF, Eichenfield LF, Swalwell CI, Jones MC. Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy? Am J Med Genet 1994;53:141-148. (Pubitemid 24335895)
12. Kutsche K, Werner W, Bartsch O, von der Wense A, Meinecke P, Gal A. Microphthalmia with linear skin defects syndrome (MLS): a male with a mosaic paracentric inversion of Xp. Cytogenet Genome Res 2002;99:297-302. (Pubitemid 37467857)
13. Abramovitz M, Ordanic-Kodani M, Wang Y, et al. Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. Biotechniques 2008;44:417-423. (Pubitemid 351498195)
14. April C, Klotzle B, Royce T, et al. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One 2009;4:e8162.
15. Fan J-B, Yeakley JM, Bibikova M, et al. A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 2004;14:878-885. (Pubitemid 38660505)
16. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868. (Pubitemid 29003722)
17. Saldanha AJ. Java Treeview: extensible visualization of microarray data. Bioinformatics 2004;20:3246-3248. (Pubitemid 39619217)
18. Cooper LA, Gutman DA, Long Q, et al. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PLoS One 2010;5:e12548.
19. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-5121. (Pubitemid 32397092)
20. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 2009; 69:709-717.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
22. Wang HQ, Du ZX, Liu BQ, et al. TNF-related apoptosis-inducing ligand suppresses PRDX4 expression. FEBS Lett 2009;583:1511-1515.
23. Dezso Z, Nikolsky Y, Sviridov E, et al. A comprehensive functional analysis of tissue specificity of human gene expression. BMC Biol 2008;6:49.
24. Bolliger MF, Frei K, Winterhalter KH, Gloor SM. Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression. Biochem J 2001;356:581-588. (Pubitemid 32532371)
25. Palmer S, Groves N, Schindeler A, et al. The small muscle-specific protein Csl modifies cell shape and promotes myocyte fusion in an insulin-like growth factor 1-dependent manner. J Cell Biol 2001; 153:985-998.
26. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nature Rev 2008;7:827-840.
27. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:217-225.
28. Kunes P, Holubcova S, Kolachova M, Krejsek J. Interleukin-33, a novel member of the IL-1/IL-18 cytokine family, in cardiology and cardiac surgery. Thorac Cardiovasc Surg 2010;58:443-449.
29. Kuroska-Stolarska M, Hueber A, Stolarski B, McInnes IB. Interleukin-33: a novel mediator with a role in distinct disease pathologies. J Intern Med 2011;269:29-35.
30. Zechner D, Craig R, Hanford DS, McDonough PM, Sabbadini RA, Glembotski CC. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinasedependent manner. J Biol Chem 1998;273:8232-8239. (Pubitemid 28168880)
31. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-1549. (Pubitemid 46871338)
32. Yin H, Li XY, Zhang BB, et al. IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation. Transplantation 2010;89:1189-1197.
33. Yagami A, Orihara K, Morita H, et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 2010;185:5743-5750.
34. Marvie P, Lisbonne M, L'helgoualc'h A, et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 2010;14:1726-1739.
35. Ghavami S, Kerkhoff C, Los M, Hashemi M, Sorg C, Karami- Tehrani F. Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukoc Biol 2004;76:169-175. (Pubitemid 38857184)
36. Ghavami S, Rashedi I, Dattilo BM, et al. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 2008;83:1484-1492. (Pubitemid 351960330)
37. Boyd JH, Kan B, Roberts H,Wang Y,Walley KR. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 2008;102:1239-1246.
38. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762-3771. (Pubitemid 39643922)